
Vepdegestrant
May 7, 2026 - 00:11:35
Radio and PodcastLive Radio & Podcasts
This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pCR rates in dMMR colon cancer. Real world rates of PJP suggest room for improvement in prophylaxis, especially those...
IMHOTEP, PJP, and more is an episode from OncoPharm by OncoPharmPod. This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pCR rates in dMMR colon cancer. Real world rates of PJP suggest room...
This episode belongs to OncoPharm.
Use the player on this page to stream the episode online.
Published May 14, 2026, 00:09:59 long, audio available.
This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pCR rates in dMMR colon cancer. Real world rates of PJP suggest room for improvement in prophylaxis, especially those on corticosteroids + additional immunosuppressants. Daraxonrasib given expanded access by FDA before approval: And yes, the ivermectin boom was real: Check out the Oncology Insights Newsletter:
You can listen to IMHOTEP, PJP, and more online on Radio and Podcast. Open the player on this page to stream the available audio.
IMHOTEP, PJP, and more is an episode from OncoPharm by OncoPharmPod.
This episode is 00:09:59 long.
This episode was published on May 14, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.